LL-37 is a 37-amino acid peptide derived from the C-terminal portion of the human cathelicidin antimicrobial protein (hCAP-18). It has been studied for its broad-spectrum antimicrobial activity as well as its role in modulating inflammation, promoting angiogenesis, and supporting tissue regeneration.
Research has explored LL-37’s potential in models involving chronic wounds, skin infections, immune signaling, and even tumor microenvironment interactions due to its regulatory influence on innate immunity and cell migration.
This compound is offered as a lyophilized powder in sterile, unlabeled glass vials to ensure purity and versatility in research settings. Our 10-vial research kits are produced under stringent quality control protocols and are independently batch-tested for identity and purity.
Each vial is intended for in vitro use only. Not for human consumption. Not for therapeutic or diagnostic purposes.
